Plasma fatty acid binding protein 4 and risk of sudden cardiac death in older adults

Luc Djoussé, Marlena Maziarz, Mary L. Biggs, Joachim H. Ix, Susan J. Zieman, Jorge Kizer, Rozenn N. Lemaitre, Dariush Mozaffarian, Russell P. Tracy, Kenneth J. Mukamal, David S. Siscovick, Nona Sotoodehnia

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Although fatty acid binding protein 4 (FABP4) may increase risk of diabetes and exert negative cardiac inotropy, it is unknown whether plasma concentrations of FABP4 are associated with incidence of sudden cardiac death (SCD). We prospectively analyzed data on 4,560 participants of the Cardiovascular Health Study. FABP4 was measured at baseline using ELISA, and SCD events were adjudicated through review of medical records. We used Cox proportional hazards to estimate effect measures. During a median followup of 11.8 years, 146 SCD cases occurred. In a multivariable model adjusting for demographic, lifestyle, and metabolic factors, relative risk of SCD associated with each higher standard deviation (SD) of plasma FABP4 was 1.15 (95% CI: 0.95-1.38), P = 0.15. In a secondary analysis stratified by prevalent diabetes status, FABP4 was associated with higher risk of SCD in nondiabetic participants, (RR per SD higher FABP4: 1.33 (95% CI: 1.07-1.65), P = 0.009) but not in diabetic participants (RR per SD higher FABP4: 0.88 (95% CI: 0.62-1.27), P = 0.50), P for diabetes-FABP4 interaction 0.049. In summary, a single measure of plasma FABP4 obtained later in life was not associated with the risk of SCD in older adults overall. Confirmation of our post-hoc results in nondiabetic people in other studies is warranted.

Original languageEnglish (US)
Article number181054
JournalCardiology Research and Practice
Volume1
Issue number1
DOIs
StatePublished - 2013

Fingerprint

Fatty Acid-Binding Proteins
Sudden Cardiac Death
Blood Proteins
Medical Records
Life Style
Enzyme-Linked Immunosorbent Assay
Demography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Djoussé, L., Maziarz, M., Biggs, M. L., Ix, J. H., Zieman, S. J., Kizer, J., ... Sotoodehnia, N. (2013). Plasma fatty acid binding protein 4 and risk of sudden cardiac death in older adults. Cardiology Research and Practice, 1(1), [181054]. https://doi.org/10.1155/2013/181054

Plasma fatty acid binding protein 4 and risk of sudden cardiac death in older adults. / Djoussé, Luc; Maziarz, Marlena; Biggs, Mary L.; Ix, Joachim H.; Zieman, Susan J.; Kizer, Jorge; Lemaitre, Rozenn N.; Mozaffarian, Dariush; Tracy, Russell P.; Mukamal, Kenneth J.; Siscovick, David S.; Sotoodehnia, Nona.

In: Cardiology Research and Practice, Vol. 1, No. 1, 181054, 2013.

Research output: Contribution to journalArticle

Djoussé, L, Maziarz, M, Biggs, ML, Ix, JH, Zieman, SJ, Kizer, J, Lemaitre, RN, Mozaffarian, D, Tracy, RP, Mukamal, KJ, Siscovick, DS & Sotoodehnia, N 2013, 'Plasma fatty acid binding protein 4 and risk of sudden cardiac death in older adults', Cardiology Research and Practice, vol. 1, no. 1, 181054. https://doi.org/10.1155/2013/181054
Djoussé, Luc ; Maziarz, Marlena ; Biggs, Mary L. ; Ix, Joachim H. ; Zieman, Susan J. ; Kizer, Jorge ; Lemaitre, Rozenn N. ; Mozaffarian, Dariush ; Tracy, Russell P. ; Mukamal, Kenneth J. ; Siscovick, David S. ; Sotoodehnia, Nona. / Plasma fatty acid binding protein 4 and risk of sudden cardiac death in older adults. In: Cardiology Research and Practice. 2013 ; Vol. 1, No. 1.
@article{5d86f5d3038f4efaa871c41120741dac,
title = "Plasma fatty acid binding protein 4 and risk of sudden cardiac death in older adults",
abstract = "Although fatty acid binding protein 4 (FABP4) may increase risk of diabetes and exert negative cardiac inotropy, it is unknown whether plasma concentrations of FABP4 are associated with incidence of sudden cardiac death (SCD). We prospectively analyzed data on 4,560 participants of the Cardiovascular Health Study. FABP4 was measured at baseline using ELISA, and SCD events were adjudicated through review of medical records. We used Cox proportional hazards to estimate effect measures. During a median followup of 11.8 years, 146 SCD cases occurred. In a multivariable model adjusting for demographic, lifestyle, and metabolic factors, relative risk of SCD associated with each higher standard deviation (SD) of plasma FABP4 was 1.15 (95{\%} CI: 0.95-1.38), P = 0.15. In a secondary analysis stratified by prevalent diabetes status, FABP4 was associated with higher risk of SCD in nondiabetic participants, (RR per SD higher FABP4: 1.33 (95{\%} CI: 1.07-1.65), P = 0.009) but not in diabetic participants (RR per SD higher FABP4: 0.88 (95{\%} CI: 0.62-1.27), P = 0.50), P for diabetes-FABP4 interaction 0.049. In summary, a single measure of plasma FABP4 obtained later in life was not associated with the risk of SCD in older adults overall. Confirmation of our post-hoc results in nondiabetic people in other studies is warranted.",
author = "Luc Djouss{\'e} and Marlena Maziarz and Biggs, {Mary L.} and Ix, {Joachim H.} and Zieman, {Susan J.} and Jorge Kizer and Lemaitre, {Rozenn N.} and Dariush Mozaffarian and Tracy, {Russell P.} and Mukamal, {Kenneth J.} and Siscovick, {David S.} and Nona Sotoodehnia",
year = "2013",
doi = "10.1155/2013/181054",
language = "English (US)",
volume = "1",
journal = "Cardiology Research and Practice",
issn = "2090-8016",
publisher = "Hindawi Publishing Corporation",
number = "1",

}

TY - JOUR

T1 - Plasma fatty acid binding protein 4 and risk of sudden cardiac death in older adults

AU - Djoussé, Luc

AU - Maziarz, Marlena

AU - Biggs, Mary L.

AU - Ix, Joachim H.

AU - Zieman, Susan J.

AU - Kizer, Jorge

AU - Lemaitre, Rozenn N.

AU - Mozaffarian, Dariush

AU - Tracy, Russell P.

AU - Mukamal, Kenneth J.

AU - Siscovick, David S.

AU - Sotoodehnia, Nona

PY - 2013

Y1 - 2013

N2 - Although fatty acid binding protein 4 (FABP4) may increase risk of diabetes and exert negative cardiac inotropy, it is unknown whether plasma concentrations of FABP4 are associated with incidence of sudden cardiac death (SCD). We prospectively analyzed data on 4,560 participants of the Cardiovascular Health Study. FABP4 was measured at baseline using ELISA, and SCD events were adjudicated through review of medical records. We used Cox proportional hazards to estimate effect measures. During a median followup of 11.8 years, 146 SCD cases occurred. In a multivariable model adjusting for demographic, lifestyle, and metabolic factors, relative risk of SCD associated with each higher standard deviation (SD) of plasma FABP4 was 1.15 (95% CI: 0.95-1.38), P = 0.15. In a secondary analysis stratified by prevalent diabetes status, FABP4 was associated with higher risk of SCD in nondiabetic participants, (RR per SD higher FABP4: 1.33 (95% CI: 1.07-1.65), P = 0.009) but not in diabetic participants (RR per SD higher FABP4: 0.88 (95% CI: 0.62-1.27), P = 0.50), P for diabetes-FABP4 interaction 0.049. In summary, a single measure of plasma FABP4 obtained later in life was not associated with the risk of SCD in older adults overall. Confirmation of our post-hoc results in nondiabetic people in other studies is warranted.

AB - Although fatty acid binding protein 4 (FABP4) may increase risk of diabetes and exert negative cardiac inotropy, it is unknown whether plasma concentrations of FABP4 are associated with incidence of sudden cardiac death (SCD). We prospectively analyzed data on 4,560 participants of the Cardiovascular Health Study. FABP4 was measured at baseline using ELISA, and SCD events were adjudicated through review of medical records. We used Cox proportional hazards to estimate effect measures. During a median followup of 11.8 years, 146 SCD cases occurred. In a multivariable model adjusting for demographic, lifestyle, and metabolic factors, relative risk of SCD associated with each higher standard deviation (SD) of plasma FABP4 was 1.15 (95% CI: 0.95-1.38), P = 0.15. In a secondary analysis stratified by prevalent diabetes status, FABP4 was associated with higher risk of SCD in nondiabetic participants, (RR per SD higher FABP4: 1.33 (95% CI: 1.07-1.65), P = 0.009) but not in diabetic participants (RR per SD higher FABP4: 0.88 (95% CI: 0.62-1.27), P = 0.50), P for diabetes-FABP4 interaction 0.049. In summary, a single measure of plasma FABP4 obtained later in life was not associated with the risk of SCD in older adults overall. Confirmation of our post-hoc results in nondiabetic people in other studies is warranted.

UR - http://www.scopus.com/inward/record.url?scp=84896311555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896311555&partnerID=8YFLogxK

U2 - 10.1155/2013/181054

DO - 10.1155/2013/181054

M3 - Article

AN - SCOPUS:84896311555

VL - 1

JO - Cardiology Research and Practice

JF - Cardiology Research and Practice

SN - 2090-8016

IS - 1

M1 - 181054

ER -